Similar articles

Abstract: Objective: Microcapsule chemoembolism is a promising treatment of tumors. We describe a deep lingual arterial embolization of tongue carcinoma with microcapsuled carboplatinum. Methods: Lingual artery cast specimens from cadavers were microscopically examined, and 78 patients with tongue cancer were recruited and treated with the deep lingual arterial embolization therapy. Results: Microcapsule embolism occurred approximately at the fifth or sixth level of the deep lingual artery branches. The five-year survival rate was 88.5% (69 out of 78), and the ten-year survival rate 52.6% (41 out of 78). Conclusion: The deep lingual arterial embolization of tongue carcinoma with microcapsuled carboplatinum is an effective therapy to treat carcinoma in mid-margin or mid-body of the tongue.

[1] Diaco, D.S., Hajarizadeh, H., Mueller, C.R., Fletcher, W.S., Pommier, R.F., Woltering, E.A., 1995. Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization. Am. J. Surg., 169(5):523-528.

[2] Dockery, P., Fraher, J., 2007. The quantification of vascular beds: a stereological approach. Exp. Mol. Pathol., 82(2):110-120.

[3] Esteban, J.M., Gil, J., 2002. Therapeutic effect of chemoembolization therapy on hepatocellular carcinoma: evaluation with contrast-enhanced power Doppler sonography and contrast-enhanced harmonic imaging. Acad. Radiol., 9(2):s382-s383.

[4] Gu, G.H., Huang, J.Q., He, H., 2002. Sequential-release of anticancer drugs microcapsulated with ethylcellulose. Chin. Med. J., 115(11):1730-1732.

[5] Harris, M., Gibbs, P., Cebon, J., Jones, R., Sewell, R., Schelleman, T., Angus, P., 2001. Hepatocellular carcinoma and chemoembolization. Intern. Med. J., 31(9):517-522.

[6] Hayashi, P.H., Ludkowski, M., Forman, L.M., Osgood, M., Johnson, S., Kugelmas, M., 2004. Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am. J. Transplant., 4(5):782-787.

[7] Huang, Y.H., Wu, J.C., Chen, S.C., Chen, C.H., Chang, J.H., Huo, T.I., 2006. Survival benefit of transcatheter arterial chemoembolizaton in patients with hepatocellular carcinoma larger than 10 cm in diameter. Aliment. Pharmacol. Ther., 23(1):129-135.

[8] Iguchi, H., Kusuki, M., Nakamura, A., Kanazawa, A., Hachiya, K., Yamane, H., 2006. Outcome of preoperative concurrent chemoradiotherapy and surgery for resectable lingual squamous cell carcinoma greater than 3 cm: the possibility of less extensive surgery. Oral Oncol., 42(4):391-397.

[9] Jang, M.K., Lee, H.C., Kim, I.S., Lim, Y.S., Chung, Y.H.W.A., Lee, Y.S., 2004. Role of additional angiography and chemoembolization in patients with hepatocellular carcinoma who achieved complete necrosis following transarterial chemoembolization. J. Gastroenterol. Hepatol., 19(9):1074-1080.

[10] Kato, T., Nemoto, R., Mori, H., Takahashi, M., Harada, M., 1981. Arterial chemoembolization with mitomycin C microcapsules in the treatment of primary or secondary carcinoma of the kidney, liver, bone and intrapelvic organs. Cancer, 48(3):674-680.

[11] Kimura, Y., Ariji, Y., Gotoh, M., Toyoda, T., Kato, M., Kawamata, A., 2001. Doppler sonography of the deep lingual artery. Acta Radiol., 42(3):306-311.

[12] Kovács, A.F., Turowski, B., 2002. Chemoembolization of oral and oropharyngeal cancer using a high-dose cisplatin crystal suspension and degradable starch microspheres. Oral Oncol., 38(1):87-95.

[13] Munro, N.P., Woodhams, S., Nawrocki, J.D., Fletcher, M.S., Thomas, P.J., 2003. The role of transarterial embolization in the treatment of renal cell carcinoma. BJU Int., 92(3):240.

[14] Ross, C.J.D., Chang, P.L., 2002. Development of small alginate microcapsules for recombinant gene product delivery to the rodent brain. J. Biomater. Sci. Polym. Ed., 13(8):953-962.

[15] Ruben, R.P., Tim, O.L., Murat, B., Corrina, C.M.M., Timm, K., Michael, G., 2005. Prospective analysis of German patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization with or without prophylactic antibiotic therapy. J. Gastroenterol. Hepatol., 20(7):1134.

[16] Shang, Z.J., Li, Z.B., Li, J.R., 2006. VEGF is up-regulated by hypoxic stimulation and related to tumour angiogenesis and severity of disease in oral squamous cell carcinoma: in vitro and in vivo studies. Int. J. Oral Maxillofac. Surg., 35(6):533-538.

[17] Sun, C.X., Yang, M.D., Huang, J.Q., Zhang, M., 1997. The scanning electronic microscope study of human lingual artery cast model. Chin. J. Stomatol., 32(3):190 (in Chinese).

[18] Tsurumaru, D., Kuroiwa, T., Yabuuchi, H., Hirata, H., Higaki, Y., Tomita, K., 2007. Efficacy of intra-arterial infusion chemotherapy for head and neck cancers using coaxial catheter technique: initial experience. Cardiovasc. Intervent. Radiol., 30(2):207-211.

[19] Uehara, M., Sano, K., Ikeda, H., Sekine, J., Irie, A., Toyota, T., 2004. Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma. Oral Oncol., 40(3):321-325.

[20] Uraki, J., Yamakado, K., Nakatsuka, A., Takeda, K., 2004. Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors. Eur. J. Radiol., 51(1):12-18.

[21] Veness, M.J., 1999. Tongue cancer in younger patients. Aust. Radiol., 43(1):76-82.

[22] Veness, M.J., Morgan, G.J., Sathiyaseelan, Y., Gebski, V., 2003. Anterior tongue cancer: age is not a predictor of outcome and should not alter treatment. ANZ J. Surg., 73(11):899-905.